Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric study

被引:2
|
作者
Marques, Ana [1 ,2 ,3 ,53 ]
Macias, Elise [1 ,2 ,3 ]
Pereira, Bruno [4 ]
Durand, Elodie [1 ,2 ,3 ]
Chassain, Carine [1 ,2 ,3 ]
Vidal, Tiphaine [1 ,2 ,3 ]
Defebvre, Luc [5 ,6 ]
Carriere, Nicolas [5 ,6 ]
Fraix, Valerie [7 ,8 ]
Moro, Elena [7 ,8 ]
Thobois, Stephane [8 ,9 ,10 ,11 ]
Metereau, Elise [8 ,9 ,10 ,11 ]
Mangone, Graziella [12 ,13 ,14 ,15 ]
Vidailhet, Marie [12 ,13 ,14 ,15 ]
Corvol, Jean-Christophe [12 ,13 ,14 ,15 ]
Lehericy, Stephane [13 ,49 ,50 ,51 ,52 ]
de Champfleur, Nicolas Menjot [16 ,17 ]
Geny, Christian [18 ,19 ]
Spampinato, Umberto [20 ,21 ,22 ]
Meissner, Wassilios G. [20 ,21 ,23 ,24 ,54 ]
Frismand, Solene [25 ,26 ]
Schmitt, Emmanuelle [27 ]
de Maindreville, Anne Doe [28 ,29 ]
Portefaix, Christophe [30 ,31 ]
Remy, Philippe [32 ,33 ,34 ,35 ,36 ]
Fenelon, Gilles [32 ,33 ,34 ,35 ,36 ]
Houeto, Jean Luc [37 ,38 ,39 ,55 ]
Colin, Olivier [37 ,40 ,41 ]
Rascol, Olivier [42 ,43 ,44 ,45 ]
Peran, Patrice [46 ]
Bonny, Jean-Marie [47 ,48 ]
Fantini, Maria Livia [1 ,2 ,3 ]
Durif, Franck [1 ,2 ,3 ]
机构
[1] Univ Clermont Auvergne, Inst Pascal, CNRS, Clermont Auvergne INP,IGCNC, Clermont Ferrand, France
[2] Clermont Ferrand Univ Hosp, Neurol Dept, Clermont Ferrand, France
[3] Clermont Ferrand Univ Hosp, NS PARK FCRIN Network, Clermont Ferrand, France
[4] Clermont Ferrand Univ Hosp, Biostat Unit DRCI, Clermont Ferrand, France
[5] Univ Lille, Dept Movement Disorder, Inserm 1172, Lille, France
[6] Univ Lille, NS PARK FCRIN Network, Inserm 1172, Lille, France
[7] Univ Grenoble Alpes, Grenoble Inst Neurosci, Serv Neurol, CHU Grenoble, Grenoble, France
[8] NS PARK FCRIN Network, Grenoble, France
[9] CNRS, Inst Sci Cognit Marc Jeannerod, UMR 5229, CNRS, Lyon, France
[10] Univ Claude Bernard Lyon 1, Lyon, France
[11] Hop Neurol & Neurochirurg P Wertheimer, Hosp Civils Lyon, Serv Neurol C, Lyon, France
[12] Sorbonne Univ, Dept Neurol, Paris, France
[13] Sorbonne Univ, NS PARK FCRIN Network, Paris, France
[14] AP HP, Inst Cerveau ICM, Paris, France
[15] Hop La Pitie Salpetriere, CNRS 7225, CIC Neurosci, Inserm 1127, Paris, France
[16] Montpellier Univ Hosp Ctr, Gui de Chauliac Hosp, Dept Neuroradiol, Montpellier, France
[17] CHRU Montpellier, Inst Imagerie Fonct Humaine, I2FH, Hop Gui de Chauliac, Montpellier, France
[18] Montpellier Univ, Montpellier Univ Hosp, Dept Geriatr, Montpellier, France
[19] Montpellier Univ, Montpellier Univ Hosp, NS PARK FCRIN Network, Montpellier, France
[20] CHU Bordeaux, Serv Neurol Malad Neurodegenerat, F-33000 Bordeaux, France
[21] CHU Bordeaux, NS PARK FCRIN Network, F-33000 Bordeaux, France
[22] Univ Bordeaux, Team P3TN, INCIA UMR 5287, CNRS, Bordeaux, France
[23] Univ Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, Bordeaux, France
[24] Univ Otago, Dept Med, Christchurch, New Zealand
[25] Nancy Univ Hosp Ctr, Dept Neurol, Nancy, France
[26] Nancy Univ Hosp Ctr, NS PARK FCRIN Network, Nancy, France
[27] Nancy Univ Hosp Ctr, Dept Neuroradiol, Nancy, France
[28] Hop Maison Blanche, Dept Neurol, Reims, France
[29] Hop Maison Blanche, NS PARK FCRIN Network, Reims, France
[30] Hop Maison Blanche, Dept Radiol, Reims, France
[31] Univ Reims, CReSTIC Lab, Reims, France
[32] CHU Henri Mondor, Ctr Expert Parkinson, Creteil, France
[33] CHU Henri Mondor, NS PARK FCRIN Network, Creteil, France
[34] Univ Paris Est Creteil, AP HP, Creteil, France
[35] Univ Paris Est Creteil, Fac Sante, Equipe Neuropsychol Intervent, INSERM IMRB, Creteil, France
[36] Paris Sorbonne Univ, Ecole Normale Super, Creteil, France
[37] Univ Poitiers, Ctr Invest Clin CIC1402, INSERM, CHU Poitiers, Poitiers, France
[38] Serv Neurol, Poitiers, France
[39] NS PARK FCRIN Network, Poitiers, France
[40] CH Brive la Gaillarde, Serv Neurol, Poitiers, France
[41] CH Brive la Gaillarde, NS PARK FCRIN Network, Poitiers, France
[42] CHU Toulouse, Ctr Expert Parkinson, Dept Pharmacol Clin, INSERM,Ctr Invest Clin CIC 1436,UMR 1214 TONIC,Ne, Toulouse, France
[43] CHU Toulouse, Dept Neurosci, Ctr Expert Parkinson, INSERM,Ctr Invest Clin CIC 1436,UMR 1214 TONIC,Ne, Toulouse, France
[44] CHU Toulouse, NS PARK FCRIN Network, INSERM, Toulouse, France
[45] Univ Toulouse 3, Toulouse, France
[46] Univ Toulouse, Toulouse NeuroImaging Ctr, ToNIC, INSERM,UPS, Toulouse, France
[47] INRAE, UR QuaPA, F-63122 St Genes Champanelle, France
[48] INRAE, AgroResonance, Nucl Magnet Resonance Facil Agron Food & Hlth, F-2018 St Genes Champanelle, France
[49] Sorbonne Univ, Dept Neuroradiol, Paris, France
[50] AP HP, Inst Cerveau ICM, Paris, France
关键词
Parkinson's disease; Volumetric changes; Brain atrophy; Clinical progression; Longitudinal study; RATING-SCALE; MATTER CHANGES; ATROPHY; PROGRESSION; VALIDATION; GAIT;
D O I
10.1007/s00415-023-11947-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundLongitudinal measures of structural brain changes using MRI in relation to clinical features and progression patterns in PD have been assessed in previous studies, but few were conducted in well-defined and large cohorts, including prospective clinical assessments of both motor and non-motor symptoms.ObjectiveWe aimed to identify brain volumetric changes characterizing PD patients, and determine whether regional brain volumetric characteristics at baseline can predict motor, psycho-behavioral and cognitive evolution at one year in a prospective cohort of PD patients.MethodsIn this multicentric 1 year longitudinal study, PD patients and healthy controls from the MPI-R2* cohort were assessed for demographical, clinical and brain volumetric characteristics. Distinct subgroups of PD patients according to motor, cognitive and psycho-behavioral evolution were identified at the end of follow-up.ResultsOne hundred and fifty PD patients and 73 control subjects were included in our analysis. Over one year, there was no significant difference in volume variations between PD and control subjects, regardless of the brain region considered. However, we observed a reduction in posterior cingulate cortex volume at baseline in PD patients with motor deterioration at one year (p = 0.017). We also observed a bilateral reduction of the volume of the amygdala (p = 0.015 and p = 0.041) and hippocampus (p = 0.015 and p = 0.053) at baseline in patients with psycho-behavioral deterioration, regardless of age, dopaminergic treatment and center.ConclusionBrain volumetric characteristics at baseline may predict clinical trajectories at 1 year in PD as posterior cingulate cortex atrophy was associated with motor decline, while amygdala and hippocampus atrophy were associated with psycho-behavioral decline.
引用
收藏
页码:6033 / 6043
页数:11
相关论文
共 50 条
  • [1] Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study
    Ana Marques
    Elise Macias
    Bruno Pereira
    Elodie Durand
    Carine Chassain
    Tiphaine Vidal
    Luc Defebvre
    Nicolas Carriere
    Valerie Fraix
    Elena Moro
    Stéphane Thobois
    Elise Metereau
    Graziella Mangone
    Marie Vidailhet
    Jean-Christophe Corvol
    Stéphane Lehéricy
    Nicolas Menjot de Champfleur
    Christian Geny
    Umberto Spampinato
    Wassilios G. Meissner
    Solène Frismand
    Emmanuelle Schmitt
    Anne Doé de Maindreville
    Christophe Portefaix
    Philippe Remy
    Gilles Fénelon
    Jean Luc Houeto
    Olivier Colin
    Olivier Rascol
    Patrice Peran
    Jean-Marie Bonny
    Maria Livia Fantini
    Franck Durif
    Journal of Neurology, 2023, 270 : 6033 - 6043
  • [2] Rate of clinical progression in Parkinson's disease. A prospective study
    Schrag, Anette
    Dodel, Richard
    Spottke, Annika
    Bornschein, Bernhard
    Siebert, Uwe
    Quinn, Niall P.
    MOVEMENT DISORDERS, 2007, 22 (07) : 938 - 945
  • [3] The longitudinal volumetric and shape changes of subcortical nuclei in Parkinson's disease
    Yang, Wenyi
    Bai, Xueqin
    Guan, Xiaojun
    Zhou, Cheng
    Guo, Tao
    Wu, Jingjing
    Xu, Xiaojun
    Zhang, Minming
    Zhang, Baorong
    Pu, Jiali
    Tian, Jun
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [4] Prospective Study of Lung Function with Prodromal, Clinical Parkinson's Disease, and Mortality
    Chen, Xiao
    Zhang, Zhicheng
    Tong, Lin
    Wang, Han
    Xu, Xinming
    Sun, Liang
    Li, Yaqi
    Gao, Xiang
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 (07) : 1427 - 1439
  • [5] Unilateral MRgFUS subthalamotomy in Parkinson's disease (PD) : A prospective clinical study
    Armengou-Garcia, L.
    Sanchez-Catasus, C.
    Aviles Olmos, I.
    Jimenez-Huete, A.
    Montoya Murillo, G.
    Gorospe Osinalde, A.
    Martin Bastida, A.
    Gonzalez-Quarante, L.
    Guridi Legarra, J.
    Rodriguez-Oroz, M. C.
    MOVEMENT DISORDERS, 2024, 39 : S540 - S541
  • [6] Ultrasonographic and clinical correlates in patients with idiopathic Parkinson's disease: a prospective study
    Lauckaite, K.
    Rastenyte, D.
    Surkiene, D.
    Vaitkus, A.
    Gleizniene, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 318 - 318
  • [7] Prospective study of hallucinations in Parkinson's disease
    Dayal, P
    Dayal, P
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 291 - 291
  • [8] Clinical trajectories and biomarkers for weight variability in early Parkinson's disease
    Urso, Daniele
    van Wamelen, Daniel J.
    Batzu, Lucia
    Leta, Valentina
    Staunton, Juliet
    Pineda-Pardo, Jose A.
    Logroscino, Giancarlo
    Sharma, Jagdish
    Ray Chaudhuri, K.
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [9] Distinctive clinical and imaging trajectories in SWEDD and Parkinson's disease patients
    Boccalini, Cecilia
    Nicastro, Nicolas
    Perani, Daniela
    Garibotto, Valentina
    NEUROIMAGE-CLINICAL, 2024, 42
  • [10] Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease
    Daniele Urso
    Daniel J. van Wamelen
    Lucia Batzu
    Valentina Leta
    Juliet Staunton
    José A. Pineda-Pardo
    Giancarlo Logroscino
    Jagdish Sharma
    K. Ray Chaudhuri
    npj Parkinson's Disease, 8